CompletedNot Applicable

Impact of Lung Boost Device on Ventilatory Functions and Fatigue in Patients With Interstitial Lung Diseases

Egypt40 participantsStarted 2025-05-29

Plain-language summary

The purpose of this study will be to determine the effect of lung boost exercise on ventilatory functions, fatigue, and physical function capacity in Interstitial lung disease patients.

Who can participate

Age range45 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Forty female patients have Interstitial lung disease .
✓. All patients diagnosed as ILD on clinical and radiological basis.
✓. Age will range between 45 to 55 years old .
✓. All patients will be with mild hypoxemia range from 90 to 92 oxygen saturation
✓. They have Interstitial lung disease for at least 3 years ago.
✓. Stable in medical and hemodynamic state

Exclusion criteria

✕. Cardiovascular (as acute heart failure, unstable angina or recent myocardial infarction)
✕. Patients with other significant respiratory disorders such as acute infections, pulmonary tuberculosis, chronic obstructive pulmonary disease, asthma, bronchiectasis, lung carcinoma, and pneumothorax.
✕. cognitive impairments, history of cerebrovascular accident, active cancer will be excluded.
✕. Hepatitis, cirrhosis.
✕. Current treatment for cancer or active infection
✕. Orthopedic problem.

What they're measuring

Forced vital capacity (FVC)

Timeframe: 8 weeks

The first second of forced expiration (FEV1)

Timeframe: 8 weeks

FEV1/FVC ratio

Timeframe: 8 weeks

Fatigue Severity Scale (FSS)

Timeframe: 8 weeks

Trial details

NCT IDNCT06991153

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-29

View on ClinicalTrials.gov More Interstitial Lung Disease trials